Single center first year experience and outcomes with Impella 5.5 left ventricular assist device.

Joanna R RockCynthia A KosAnthony LemaireHirohisa IkegamiMark J RussoDanyaal MoinKenneth DulnuanDeepa Iyer

Published in: Journal of cardiothoracic surgery (2022)

Our institution's experience with the Impella 5.5® has been strongly positive with favorable outcomes and helps to establish the Impella 5.5® as a viable option for mechanical circulatory support beyond 14 days.

Keyphrases

left ventricular assist device
extracorporeal membrane oxygenation
metabolic syndrome
adipose tissue
skeletal muscle
type diabetes